載入...
CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
CD22 (Siglec 2) is a receptor predominantly restricted to B cells. It was initially characterized over 30 years ago and named “CD22” in 1984 at the 2nd International workshop in Boston (1). Several excellent reviews have detailed CD22 functions, CD22-regulated signaling pathways and B cell subsets r...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6173129/ https://ncbi.nlm.nih.gov/pubmed/30323814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02235 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|